Skip to Main Content

Paper Details

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.
Breast Cancer Res
12
2019
BCa, BCa cell line models, BCa cells, CDK4, CDK4/6, E2F1, ER, ER+, ERX-11, Estrogen, Estrogen receptor coregulator, MTT, PDEs, XDE, advanced breast cancer, coregulator, coregulators, endocrine therapy-resistant BCa cells, endocrine therapy-sensitive, estrogen, estrogen receptor, estrogen receptor-positive breast cancers, letrozole, patient, patient-derived explants, patients, reporter gene, resistant, ribociclib, tamoxifen, therapy, xenograft, xenograft tumor, xenograft-derived explants
Author NameAffiliation
Susan T WeintraubUniversity of Texas Health
Susan T WeintraubUniversity of Texas Health
Ganesh V RajUniversity of Texas Southwestern Medical Center at Dallas
Ganesh V RajSimmons Cancer Center, University of Texas Southwestern Medical Center at Dallas
  • 1 - 4

Datasets

Release 1.2